Accession 628
Title A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies
Summary The purpose of the present study was to further evaluate the biologic significance of the CD22ΔE12 molecular lesion and determine if it could serve as a molecular target for RNA interference (RNAi) therapy.
Journal EBioMedicine
Publish date December, 2014
Corresponding Author Fatih M. Uckun
E-mail uckun@usc.edu
Array Type Antibody array
Species Mus musculus
Raw data link

PMDE162

Link to PubMed

PubMed ID:25599086